Üstün, TB, Ayuso-Mateos, JL, Chatterji, S, Mathers, C, Murray, CJL. Global burden of depressive disorders in the year 2000. Br J Psychiatry
2004; 184: 386–92.
Araya, R, Rojas, G, Fritsch, R, Frank, R, Lewis, G. Inequities in mental health care after health care system reform in Chile. Am J Public Health
2006; 96: 109–13.
Saxena, S, Thornicroft, G, Knapp, M, Whiteford, H. Resources for mental health: scarcity, inequity, and inefficiency. Lancet
2007; 370: 878–89.
Mulrow, CD, Williams, JW Jr, Chiquette, E, Aguilar, C, Hitchcock-Noel, P, Lee, S, et al. Efficacy of newer medications for treating depression in primary care patients. Am J Med
2000; 108: 54–64.
Rush, AJ, Trivedi, MH, Wisniewski, SR, Nierenberg, AA, Stewart, JW, Warden, D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry
2006; 163: 1905–17.
Patel, V, Araya, R, Chatterjee, S, Chisholm, D, Cohen, A, De Silva, M, et al. Treatment and prevention of mental disorders in low-income and middle-income countries. Lancet
2007; 370: 991–1005.
Araya, R, Flynn, T, Rojas, G, Fritsch, R, Simon, G. Cost-effectiveness of a primary care treatment program for depression in low-income women in Santiago, Chile. Am J Psychiatry
2006; 163: 1379–87.
Araya, R, Rojas, G, Fritsch, R, Gaete, J, Rojas, M, Simon, G, et al. Treating depression in primary care in low-income women in Santiago, Chile: a randomised controlled trial. Lancet
2003; 361: 995–1000.
Chisholm, D, Sanderson, K, Ayuso-Mateos, JL, Saxena, S. Reducing the global burden of depression: population-level analysis of intervention cost-effectiveness in 14 world regions. Br J Psychiatry
2004; 184: 393–403.
Siskind, D, Baingana, F, Kim, J. Cost-effectiveness of group psychotherapy for depression in Uganda. J Ment Health Policy Econ
2008; 11: 127–33.
Sonnenberg, FA, Beck, JR. Markov models in medical decision making: a practical guide. Med Decis Making
1993; 13: 322–38.
Eaton, WW, Kramer, M, Anthony, JC, Dryman, A, Shapiro, S, Locke, BZ. The incidence of specific DIS/DSM-III mental disorders: data from the NIMH Epidemiologic Catchment Area Program. Acta Psychiatr Scand
1989; 79: 163–78.
Solomon, DA, Keller, MB, Leon, AC, Mueller, TI, Lavori, PW, Shea, MT, et al. Multiple recurrences of major depressive disorder. Am J Psychiatry
2000; 157: 229–33.
Stouthard, M, Essink-Bot, M, Bonsel, G. Disability weights for diseases: a modified protocol and results for a Western European region. Eur J Public Health
2000; 10: 24–30.
Mahapatra, P, Salomon, JA, Nanda, L. Measuring health state values in developing countries: results from a community survey in Andhra Pradesh. In Summary of Measures of Population Health: Concepts, Ethics, Measurement and Applications (ed Murray, CJL). WHO, 2002.
Mathers, CD, Murray, CJL, Lopez, AD, Salomon, JA, Saduna, R, Tandon, A, et al. Estimates of Healthy Life Expectancy for 191 Countries in the Year 2000: Methods and Results. WHO, 2000.
Goldney, RD, Dal Grande, E, Fisher, LJ, Wilson, D. Population attributable risk of major depression for suicidal ideation in a random and representative community sample. J Affect Disord
2003; 74: 267–72.
Heerlein, A, Valeria, C, Medina, B. Seasonal variation in suicidal deaths in Chile: its relationship to latitude. Psychopathology
2006; 39: 75–9.
Harris, EC, Barraclough, B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry
1997; 170: 205–28.
Isacsson, G, Bergman, U, Rich, CL. Epidemiological data suggest antidepressants reduce suicide risk among depressives. J Affect Disord
1996; 41: 1–8.
Geddes, JR, Carney, SM, Davies, C, Furukawa, TA, Kupfer, DJ, Frank, E, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet
2003; 361: 653–61.
Gold, MR. Cost-effectiveness in Health and Medicine. Oxford University Press, 1996.
Gaziano, TA, Opie, LH, Weinstein, MC. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet
2006; 19; 368: .
Narayan, KMV. Diabetes: the pandemic and potential solutions. In Disease Control Priorities in Developing Countries (2nd edn) (eds Jamison, DT, Breman, JG, Measham, AR, Alleyne, G, Claeson, M, Evans, DB, et al): 591–604. World Bank, 2006.
Katon, W, Rutter, C, Ludman, EJ, Von Korff, M, Lin, E, Simon, G, et al. A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry
2001; 58: 241–7.
Ellis, P. Australian and New Zealand clinical practice guidelines for the treatment of depression. Aust N Z J Psychiatry. 2004; 38: 389–407.
Vos, T, Haby, MM, Barendregt, JJ, Kruijshaar, M, Corry, J, Andrews, G. The burden of major depression avoidable by longer-term treatment strategies. Arch Gen Psychiatry
2004; 61: 1097–103.
Jovanovic, D, Kilibarda, V, Dordevic, S, Jovanovic, M, Jovic-Stosic, J, Srdic, D, et al. Bioequivalence testing of a new tablet formulation of generic fluoxetine. Eur J Drug Metab Pharmacokinet
2006; 31: 35–40.
Joynt, KE, Whellan, DJ, O'Connor, CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry
2003; 54: 248–61.
da Silva Lima, AF, de Almeida Fleck, MP. Subsyndromal depression: an impact on quality of life?
J Affect Disord
2007; 100: 163–9.
Broadhead, WE, Blazer, DG, George, LK, Tse, CK. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA
1990; 264: 2524–8.
Kleinman, A. Culture and depression. N Engl J Med
2004; 351: 951–3.